Enrolment in primary care networks: Impact on outcomes and processes of care for patients with diabetes

CMAJ. Canadian Medical Association Journal

Volumn 184, Issue 2, 2012, Pages

  Manns, Braden J ^a,b,c   Tonelli, Marcello ^b,d   Zhang, Jianguo ^a,b   Campbell, David J T ^b   Sargious, Peter ^a   Ayyalasomayajula, Bharati ^b   Clement, Fiona ^a,b   Johnson, Jeffrey A ^d   Laupacis, Andreas ^e   Lewanczuk, Richard ^d   McBrien, Kerry ^a,b   Hemmelgarn, Brenda R ^a,b,c  

^a UNIVERSITY OF CALGARY   (Canada)

^b Alberta Kidney Disease Network   (Canada)

^c LIBIN CARDIOVASCULAR INSTITUTE OF ALBERTA   (Canada)

^d UNIVERSITY OF ALBERTA   (Canada)

^e ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AMBULATORY CARE; ARTICLE; CANADA; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; EMERGENCY HEALTH SERVICE; FEMALE; GLYCEMIC CONTROL; HEALTH CARE UTILIZATION; HOSPITAL ADMISSION; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; MAJOR CLINICAL STUDY; MALE; OPHTHALMOLOGY; OPTOMETRY; PATIENT CARE; PRIMARY MEDICAL CARE; PROGNOSIS; PROPENSITY SCORE;

EID: 84863045047     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.110755     Document Type: Article

References (31)

1. Simpson SH, Corabian P, Jacobs P, et al. The cost of major comorbidity in people with diabetes mellitus. CMAJ 2003;168:1661-7. (Pubitemid 36801929)
2. Johnson JA. Alberta diabetes atlas. Edmonton (AB): Institute of Health Economics; 2009.
3. Tonelli M, Bohm C, Pandeya S, et al. Cardiac risk factors and the use of cardioprotective medications in patients with chronic renal insufficiency. Am J Kidney Dis 2001;37:484-9. (Pubitemid 32195286)
4. Tonelli M, Gill J, Pandeya S, et al. Barriers to blood pressure control and angiotensin enzyme inhibitor use in Canadian patients with chronic renal insufficiency. Nephrol Dial Transplant 2002;17:1426-33.
5. Gaede P, Vedel P, Larsen N, et al. Multifactorial interventions and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003;348:383-93. (Pubitemid 36159355)
6. Von Korff M, Gruman J, Schaefer J, et al. Collaborative management of chronic illness. Ann Intern Med 1997;127:1097-102. (Pubitemid 28012080)
7. Alberta Primary Care Initiative [homepage]. Edmonton (AB): The Initiative; 2011. Available: www.albertapci.ca/Pages/default.aspx [accessed 2009 Dec. 30].
8. Campbell D, Sargious P, Lewanczuk R, et al. The use of chronic disease management programs for diabetes by Alberta's primary care networks. Can Fam Phys. In press.
9. Rosser WW, Colwill JM, Kasperski J, et al. Patient-centered medical homes in Ontario. N Engl J Med 2010;362:e7.
10. Rosser WW, Colwill JM, Kasperski J, et al. Progress of Ontario's family health team model: a patient-centered medical home. Ann Fam Med 2011;9:165-71.
11. Stange KC, Miller WL, Nutting PA, et al., Context for understanding the National Demonstration Project and the patient-centered medical home. Ann Fam Med, 2010; 8 Suppl 1: S2-8; S92.
12. Booth GL, Hux JE. Relationship between avoidable hospitalizations for diabetes mellitus and income level. Arch Intern Med 2003;163:101-6. (Pubitemid 36091607)
13. Canadian Institute for Health Information. Technical note: ambulatory care sensitive conditions (ACSC). Ottawa (ON): The Institute; 2010; Available: www.cihi.ca/CIHI-ext-portal/pdf/internet/DEFINITIONS-052010-EN (accessed 2011 Nov. 15).
14. Blanchard JF, Ludwig S, Wajda A, et al. Incidence and prevalence of diabetes in Manitoba, 1986-1991. Diabetes Care 1996;19: 807-11. (Pubitemid 26286983)
15. Hux JE, Ivis F, Flintoft V, et al. Diabetes in Ontario: determination of prevalence and incidence using a validated administrative data algorithm. Diabetes Care 2002;25:512-6. (Pubitemid 41103345)
16. Majumdar S. Johnson JA, Bowker SL, et al. A Canadian consensus for the standardized evaluation of quality improvement interventions in type 2 diabetes. Can J Diabetes 2005;29:220-9.
17. Colhoun HM, Betteridge DJ, Durrington PN, et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet 2004;364:685-96. (Pubitemid 39140624)
18. Brenner BM, Cooper ME, de Zeeuw D, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001;345:861-9.
19. Quan H, Khan N, Hemmelgarn BR, et al. Validation of a case definition to define hypertension using administrative data. Hypertension 2009;54:1423-8.
20. Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 2005;43:1130-9. (Pubitemid 41587600)
21. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39(Suppl 1):S1-266.
22. Rubin DB. On principles for modeling propensity scores in medical research. Pharmacoepidemiol Drug Saf 2004;13:855-7. (Pubitemid 40003820)
23. Rubin DB. Estimating causal effects from large data sets using propensity scores. Ann Intern Med 1997;127:757-63. (Pubitemid 27446562)
24. Laird NM, Ware JH. Random-effects models for longitudinal data. Biometrics 1982;38:963-74.
25. Xu Y, Cheung YB, Lam KF, et al. A simple approach to the estimation of incidence rate difference. Am J Epidemiol 2010;172:334-43.
26. Smith J, Mays N. Primary-care trusts: Do they have a future? BMJ 2005;331:1156-7. (Pubitemid 41689425)
27. Gillam S, Lewis RQ. Practice based commissioning in the UK. BMJ 2009;338:b832.
28. Higgins J. A new look at NHS commissioning. BMJ 2007;334:22-4.
29. Association of American Medical Colleges The medical home: position statement. Washington (DC): The Association; 2008.
30. Jaén CR, Ferrer RL, Miller WL, et al. Patient outcomes at 26 months in the patient-centered medical home National Demonstration Project. Ann Fam Med, 2010;8 Suppl 1:S57-67; S92.
31. Shojania KG, Ranji SR, McDonald KM, et al. Effects of quality improvement strategies for type 2 diabetes on glycemic control: a meta-regression analysis. JAMA 2006;296:427-40. (Pubitemid 44127527)